Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 114 | 2024 | 21207 | 3.960 |
Why?
|
Breast | 28 | 2024 | 1976 | 3.710 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 19 | 2023 | 934 | 2.920 |
Why?
|
Breast Diseases | 18 | 2021 | 442 | 2.040 |
Why?
|
Receptors, Estrogen | 37 | 2023 | 2253 | 1.810 |
Why?
|
Receptors, Progesterone | 28 | 2021 | 1160 | 1.530 |
Why?
|
Receptor, erbB-2 | 25 | 2023 | 2603 | 1.310 |
Why?
|
Keratins | 6 | 2015 | 499 | 1.140 |
Why?
|
Carcinoma in Situ | 8 | 2022 | 788 | 1.100 |
Why?
|
Carcinoma, Lobular | 8 | 2022 | 480 | 1.090 |
Why?
|
Carcinoma, Ductal, Breast | 11 | 2023 | 1099 | 0.890 |
Why?
|
Hyperplasia | 7 | 2022 | 1151 | 0.820 |
Why?
|
Reproductive History | 5 | 2021 | 210 | 0.790 |
Why?
|
Precancerous Conditions | 9 | 2017 | 985 | 0.770 |
Why?
|
Immunohistochemistry | 20 | 2021 | 11095 | 0.750 |
Why?
|
Estrogen Receptor alpha | 4 | 2021 | 581 | 0.730 |
Why?
|
Carcinoma, Papillary | 5 | 2022 | 793 | 0.690 |
Why?
|
Uveal Neoplasms | 4 | 2024 | 344 | 0.680 |
Why?
|
Tissue Array Analysis | 13 | 2021 | 551 | 0.580 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1155 | 0.540 |
Why?
|
BRCA2 Protein | 1 | 2021 | 802 | 0.540 |
Why?
|
Epithelium | 4 | 2021 | 1607 | 0.540 |
Why?
|
Receptors, Androgen | 6 | 2019 | 1089 | 0.500 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9419 | 0.500 |
Why?
|
Biopsy | 14 | 2024 | 6792 | 0.490 |
Why?
|
Female | 131 | 2024 | 397187 | 0.470 |
Why?
|
Biopsy, Needle | 4 | 2009 | 1623 | 0.440 |
Why?
|
Nomograms | 1 | 2015 | 236 | 0.430 |
Why?
|
Genes, BRCA1 | 4 | 2010 | 755 | 0.390 |
Why?
|
Neoplasm Invasiveness | 13 | 2016 | 3620 | 0.380 |
Why?
|
Neoplasms, Second Primary | 3 | 2024 | 1061 | 0.370 |
Why?
|
Molecular Typing | 1 | 2011 | 115 | 0.360 |
Why?
|
Humans | 151 | 2024 | 768171 | 0.360 |
Why?
|
Muscle Cells | 2 | 2009 | 195 | 0.360 |
Why?
|
Mammography | 11 | 2020 | 2433 | 0.360 |
Why?
|
Mammary Glands, Human | 4 | 2021 | 202 | 0.350 |
Why?
|
Adult | 87 | 2024 | 223646 | 0.350 |
Why?
|
Epithelial Cells | 5 | 2010 | 3703 | 0.350 |
Why?
|
Parity | 5 | 2021 | 931 | 0.330 |
Why?
|
Case-Control Studies | 22 | 2021 | 22290 | 0.320 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2846 | 0.290 |
Why?
|
Risk Factors | 41 | 2024 | 74944 | 0.290 |
Why?
|
Middle Aged | 75 | 2024 | 223487 | 0.280 |
Why?
|
Mucocele | 2 | 2022 | 51 | 0.280 |
Why?
|
Breast Cyst | 1 | 2006 | 8 | 0.270 |
Why?
|
Agaricales | 1 | 2006 | 31 | 0.270 |
Why?
|
Papilloma | 3 | 2015 | 143 | 0.260 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 703 | 0.250 |
Why?
|
Vaginal Smears | 2 | 2001 | 505 | 0.250 |
Why?
|
Prognosis | 20 | 2023 | 30009 | 0.250 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 13013 | 0.240 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2001 | 392 | 0.240 |
Why?
|
Neoadjuvant Therapy | 3 | 2020 | 2907 | 0.240 |
Why?
|
Pathology | 1 | 2008 | 270 | 0.240 |
Why?
|
Prospective Studies | 26 | 2024 | 54924 | 0.240 |
Why?
|
Mutation | 8 | 2023 | 30237 | 0.230 |
Why?
|
Integrins | 5 | 2001 | 842 | 0.230 |
Why?
|
Immunophenotyping | 4 | 2017 | 1864 | 0.230 |
Why?
|
Melanoma | 4 | 2024 | 5706 | 0.230 |
Why?
|
Laboratories | 1 | 2008 | 463 | 0.230 |
Why?
|
Nurses | 11 | 2020 | 2501 | 0.220 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9540 | 0.220 |
Why?
|
Cadherins | 4 | 2022 | 905 | 0.210 |
Why?
|
Polysaccharides | 2 | 2007 | 1024 | 0.210 |
Why?
|
Fibrocystic Breast Disease | 2 | 2013 | 103 | 0.200 |
Why?
|
Medical Records | 1 | 2008 | 1410 | 0.200 |
Why?
|
Sclerosis | 2 | 2015 | 211 | 0.200 |
Why?
|
Cohort Studies | 19 | 2021 | 41753 | 0.180 |
Why?
|
Prolactin | 1 | 2023 | 627 | 0.180 |
Why?
|
Alcohol Drinking | 5 | 2020 | 4045 | 0.180 |
Why?
|
Neoplasm Staging | 12 | 2016 | 11244 | 0.180 |
Why?
|
Gene Transfer Techniques | 6 | 2005 | 1207 | 0.180 |
Why?
|
Young Adult | 16 | 2024 | 60066 | 0.170 |
Why?
|
Odds Ratio | 8 | 2015 | 9669 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 181 | 0.170 |
Why?
|
Doxorubicin | 1 | 2006 | 2234 | 0.160 |
Why?
|
Osteoprotegerin | 1 | 2020 | 179 | 0.160 |
Why?
|
Specimen Handling | 1 | 2024 | 707 | 0.160 |
Why?
|
Postmenopause | 6 | 2015 | 2518 | 0.160 |
Why?
|
Mastectomy, Segmental | 5 | 2022 | 974 | 0.160 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 438 | 0.160 |
Why?
|
Aged | 33 | 2024 | 171502 | 0.150 |
Why?
|
Gene Expression | 6 | 2015 | 7601 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 525 | 0.150 |
Why?
|
Genetic Vectors | 5 | 2001 | 3403 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 2 | 2023 | 3740 | 0.150 |
Why?
|
Age Factors | 6 | 2021 | 18415 | 0.140 |
Why?
|
Stromal Cells | 4 | 2021 | 1337 | 0.140 |
Why?
|
Adolescent | 19 | 2021 | 89169 | 0.140 |
Why?
|
Keratin-5 | 3 | 2011 | 43 | 0.140 |
Why?
|
Aged, 80 and over | 17 | 2024 | 59626 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2001 | 577 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9016 | 0.140 |
Why?
|
Body Height | 2 | 2020 | 1565 | 0.140 |
Why?
|
Body Size | 2 | 2021 | 463 | 0.140 |
Why?
|
Pathology, Surgical | 1 | 2017 | 148 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2001 | 2043 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2004 | 1003 | 0.130 |
Why?
|
Menarche | 2 | 2021 | 538 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 630 | 0.120 |
Why?
|
Phenotype | 7 | 2020 | 16726 | 0.120 |
Why?
|
Risk | 6 | 2021 | 9613 | 0.120 |
Why?
|
Holistic Nursing | 1 | 2014 | 3 | 0.120 |
Why?
|
Keratin-6 | 2 | 2011 | 15 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1015 | 0.120 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39354 | 0.120 |
Why?
|
Metaplasia | 1 | 2015 | 326 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2022 | 975 | 0.110 |
Why?
|
Genomics | 4 | 2023 | 5926 | 0.110 |
Why?
|
Apoptosis | 2 | 2007 | 9527 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2020 | 951 | 0.110 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20225 | 0.110 |
Why?
|
Proportional Hazards Models | 10 | 2021 | 12543 | 0.110 |
Why?
|
Tumor Burden | 3 | 2016 | 1906 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2012 | 1942 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.100 |
Why?
|
Logistic Models | 6 | 2016 | 13290 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 416 | 0.100 |
Why?
|
Polylysine | 3 | 2001 | 130 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15453 | 0.100 |
Why?
|
HLA-A Antigens | 2 | 2023 | 223 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
Tumor Cells, Cultured | 6 | 2012 | 6124 | 0.100 |
Why?
|
Deoxyadenine Nucleotides | 1 | 2011 | 14 | 0.100 |
Why?
|
Crotalid Venoms | 2 | 2001 | 29 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 18065 | 0.100 |
Why?
|
Dinucleoside Phosphates | 1 | 2011 | 70 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.090 |
Why?
|
Medical Oncology | 1 | 2023 | 2346 | 0.090 |
Why?
|
Deoxyguanosine | 1 | 2011 | 96 | 0.090 |
Why?
|
DNA Adducts | 1 | 2011 | 95 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2011 | 13677 | 0.090 |
Why?
|
Oligopeptides | 4 | 2012 | 1194 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1904 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4057 | 0.090 |
Why?
|
Adiposity | 1 | 2020 | 1895 | 0.090 |
Why?
|
Interinstitutional Relations | 1 | 2012 | 235 | 0.090 |
Why?
|
Vitamin D | 2 | 2016 | 3311 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2015 | 2819 | 0.090 |
Why?
|
Breast Feeding | 1 | 2019 | 1363 | 0.090 |
Why?
|
Aspirin | 3 | 2012 | 3135 | 0.090 |
Why?
|
Risk Assessment | 10 | 2021 | 24318 | 0.090 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 408 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11878 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2011 | 2885 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2020 | 2197 | 0.080 |
Why?
|
Organ Transplantation | 1 | 2000 | 1176 | 0.080 |
Why?
|
Carcinoma, Ductal | 1 | 2010 | 97 | 0.080 |
Why?
|
Incidence | 9 | 2024 | 21538 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2491 | 0.080 |
Why?
|
Fibroadenoma | 1 | 2009 | 42 | 0.080 |
Why?
|
Pregnancy | 7 | 2024 | 30255 | 0.080 |
Why?
|
Mucins | 2 | 2022 | 570 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 598 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2009 | 171 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
United States | 15 | 2021 | 73039 | 0.080 |
Why?
|
Mastectomy | 3 | 2022 | 1862 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 384 | 0.080 |
Why?
|
Bone Resorption | 1 | 2012 | 728 | 0.080 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1514 | 0.080 |
Why?
|
Acetaminophen | 1 | 2012 | 552 | 0.080 |
Why?
|
Observer Variation | 3 | 2021 | 2621 | 0.080 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2011 | 410 | 0.080 |
Why?
|
Endometriosis | 1 | 2016 | 873 | 0.070 |
Why?
|
Time Factors | 9 | 2013 | 40220 | 0.070 |
Why?
|
Nuts | 1 | 2010 | 264 | 0.070 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 905 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 797 | 0.070 |
Why?
|
Cathepsins | 1 | 2008 | 243 | 0.070 |
Why?
|
Mastectomy, Simple | 1 | 2007 | 23 | 0.070 |
Why?
|
Basidiomycota | 1 | 2007 | 17 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2007 | 719 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2019 | 8648 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11101 | 0.070 |
Why?
|
Carcinoma, Large Cell | 1 | 2007 | 114 | 0.070 |
Why?
|
Seroma | 1 | 2007 | 75 | 0.070 |
Why?
|
Heterozygote | 2 | 2012 | 2798 | 0.070 |
Why?
|
Chemokines, CXC | 1 | 2008 | 420 | 0.070 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2006 | 68 | 0.070 |
Why?
|
Diet | 3 | 2014 | 8089 | 0.070 |
Why?
|
Exercise | 2 | 2015 | 5954 | 0.070 |
Why?
|
Keratin-14 | 1 | 2006 | 57 | 0.070 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 88 | 0.070 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2006 | 147 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 937 | 0.060 |
Why?
|
Dietary Fiber | 1 | 2010 | 767 | 0.060 |
Why?
|
Codon, Nonsense | 1 | 2007 | 287 | 0.060 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12077 | 0.060 |
Why?
|
Bile Canaliculi | 1 | 2005 | 12 | 0.060 |
Why?
|
Lysine | 3 | 2014 | 1000 | 0.060 |
Why?
|
Osteogenesis | 1 | 2012 | 1295 | 0.060 |
Why?
|
Premenopause | 3 | 2020 | 1039 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4058 | 0.060 |
Why?
|
Folic Acid | 1 | 2012 | 1337 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2810 | 0.060 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2007 | 249 | 0.060 |
Why?
|
Tamoxifen | 2 | 2009 | 966 | 0.060 |
Why?
|
Transfection | 3 | 2001 | 5756 | 0.060 |
Why?
|
Managed Care Programs | 1 | 2010 | 939 | 0.060 |
Why?
|
Carcinoid Tumor | 1 | 2006 | 225 | 0.060 |
Why?
|
Psychometrics | 1 | 2014 | 3063 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2011 | 1536 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3390 | 0.060 |
Why?
|
Neuroanatomy | 2 | 2001 | 73 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2001 | 1494 | 0.060 |
Why?
|
Lymphatic Metastasis | 4 | 2019 | 2914 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 36 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1444 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2601 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2020 | 65379 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2568 | 0.060 |
Why?
|
Pathology, Clinical | 2 | 2006 | 375 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2024 | 81760 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6082 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3604 | 0.050 |
Why?
|
Caspases | 1 | 2006 | 882 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10763 | 0.050 |
Why?
|
Tight Junctions | 1 | 2005 | 324 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13490 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2271 | 0.050 |
Why?
|
Early Detection of Cancer | 2 | 2014 | 3239 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13668 | 0.050 |
Why?
|
Dissection | 1 | 2024 | 299 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2023 | 268 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 725 | 0.050 |
Why?
|
Drug Synergism | 1 | 2006 | 1760 | 0.050 |
Why?
|
Cation Exchange Resins | 1 | 2001 | 19 | 0.050 |
Why?
|
Hemagglutinins, Viral | 1 | 2001 | 66 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1542 | 0.050 |
Why?
|
Family Health | 1 | 2006 | 1255 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2001 | 111 | 0.050 |
Why?
|
Anatomy, Artistic | 1 | 2001 | 51 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 204 | 0.050 |
Why?
|
DNA Repair | 1 | 2010 | 2050 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2001 | 139 | 0.050 |
Why?
|
Stereotaxic Techniques | 1 | 2004 | 553 | 0.050 |
Why?
|
Cytodiagnosis | 1 | 2005 | 452 | 0.050 |
Why?
|
Patient Selection | 2 | 2012 | 4260 | 0.050 |
Why?
|
Medical Illustration | 1 | 2001 | 135 | 0.040 |
Why?
|
North America | 1 | 2024 | 1289 | 0.040 |
Why?
|
Calcinosis | 1 | 2009 | 1482 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2005 | 1080 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3187 | 0.040 |
Why?
|
Respiratory Muscles | 1 | 2001 | 144 | 0.040 |
Why?
|
Chloroquine | 1 | 2001 | 276 | 0.040 |
Why?
|
Carbonated Beverages | 1 | 2021 | 210 | 0.040 |
Why?
|
Monosomy | 1 | 1999 | 52 | 0.040 |
Why?
|
Neoplasms | 3 | 2024 | 22371 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 812 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3517 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1703 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 13053 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 355 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12795 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4055 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2332 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4310 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6525 | 0.040 |
Why?
|
Reflex | 1 | 2001 | 375 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2021 | 290 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5792 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4282 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2007 | 1885 | 0.040 |
Why?
|
Elasticity | 1 | 2021 | 657 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2697 | 0.040 |
Why?
|
Peptides | 2 | 2001 | 4354 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Women's Health | 1 | 2008 | 2082 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1999 | 534 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3806 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7454 | 0.040 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 165 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7213 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14164 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14729 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 743 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2001 | 721 | 0.030 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 91 | 0.030 |
Why?
|
Cell Polarity | 1 | 2020 | 639 | 0.030 |
Why?
|
Animals | 9 | 2017 | 169285 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3556 | 0.030 |
Why?
|
Huntington Disease | 1 | 2003 | 1147 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 791 | 0.030 |
Why?
|
Beverages | 1 | 2021 | 819 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1346 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2003 | 1275 | 0.030 |
Why?
|
Ultrasonography | 1 | 2009 | 6004 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2016 | 863 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4913 | 0.030 |
Why?
|
Databases, Factual | 2 | 2001 | 8080 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3948 | 0.030 |
Why?
|
Colposcopy | 1 | 1996 | 151 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12171 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2012 | 10478 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 165 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2019 | 3474 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6610 | 0.030 |
Why?
|
Population Surveillance | 2 | 2015 | 2596 | 0.030 |
Why?
|
Case Management | 1 | 1996 | 277 | 0.030 |
Why?
|
Viral Proteins | 1 | 2001 | 1802 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5196 | 0.030 |
Why?
|
Nursing Staff | 1 | 2015 | 113 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3436 | 0.030 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 361 | 0.030 |
Why?
|
Thienamycins | 1 | 1993 | 29 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2521 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 403 | 0.030 |
Why?
|
Registries | 1 | 2009 | 8375 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2048 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2001 | 1904 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2013 | 12801 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2007 | 17142 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4178 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2009 | 1791 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8542 | 0.030 |
Why?
|
Male | 11 | 2024 | 364731 | 0.030 |
Why?
|
Menopause | 1 | 2021 | 1656 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 1993 | 179 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2021 | 6229 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2001 | 5151 | 0.020 |
Why?
|
Liver | 2 | 2005 | 7578 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2012 | 137 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2022 | 2631 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 170 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1078 | 0.020 |
Why?
|
Survival Rate | 2 | 2020 | 12840 | 0.020 |
Why?
|
Gram-Negative Bacteria | 1 | 1993 | 275 | 0.020 |
Why?
|
Students, Nursing | 1 | 2012 | 46 | 0.020 |
Why?
|
Micronutrients | 1 | 2014 | 390 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2015 | 839 | 0.020 |
Why?
|
Therapeutic Irrigation | 2 | 2005 | 297 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 15869 | 0.020 |
Why?
|
Nurse Practitioners | 1 | 2014 | 271 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2014 | 350 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2014 | 677 | 0.020 |
Why?
|
Graft Rejection | 2 | 2001 | 4492 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2012 | 428 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2011 | 405 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2012 | 279 | 0.020 |
Why?
|
Allied Health Personnel | 1 | 2012 | 156 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4648 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1758 | 0.020 |
Why?
|
Pyrroles | 1 | 2015 | 1124 | 0.020 |
Why?
|
Thrombin | 1 | 1992 | 600 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3334 | 0.020 |
Why?
|
Medical Audit | 1 | 2010 | 454 | 0.020 |
Why?
|
Cathepsin K | 1 | 2008 | 65 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3628 | 0.020 |
Why?
|
Osteoclasts | 1 | 2012 | 713 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4939 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1616 | 0.020 |
Why?
|
Boronic Acids | 1 | 2012 | 915 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3773 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1300 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1132 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6894 | 0.020 |
Why?
|
Rabbits | 3 | 2001 | 4773 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1837 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 1535 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 753 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2001 | 1524 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2873 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1836 | 0.020 |
Why?
|
Caspase 2 | 1 | 2007 | 26 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2009 | 36741 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2012 | 643 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1999 | 2195 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2627 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2013 | 1209 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1444 | 0.020 |
Why?
|
Osteoblasts | 1 | 2012 | 1153 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1281 | 0.020 |
Why?
|
Dietary Fats | 1 | 2014 | 2003 | 0.020 |
Why?
|
Caspase 8 | 1 | 2007 | 198 | 0.020 |
Why?
|
Pyrazines | 1 | 2012 | 1205 | 0.020 |
Why?
|
Cytoplasm | 1 | 2011 | 1505 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2000 | 3301 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4640 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6684 | 0.020 |
Why?
|
California | 1 | 2010 | 1438 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2012 | 997 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16044 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2732 | 0.020 |
Why?
|
Egtazic Acid | 1 | 2005 | 166 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5402 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6847 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2081 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2005 | 396 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4585 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2007 | 663 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2711 | 0.020 |
Why?
|
Mass Screening | 1 | 2001 | 5458 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4035 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14783 | 0.010 |
Why?
|
DNA Methylation | 2 | 2010 | 4428 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5028 | 0.010 |
Why?
|
Laparoscopy | 1 | 2016 | 2041 | 0.010 |
Why?
|
Caspase 3 | 1 | 2007 | 730 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13045 | 0.010 |
Why?
|
Brain | 2 | 2001 | 27362 | 0.010 |
Why?
|
Body Weight | 1 | 2015 | 4627 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4034 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1667 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 951 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7876 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2007 | 736 | 0.010 |
Why?
|
Chelating Agents | 1 | 2005 | 385 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2722 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2005 | 1163 | 0.010 |
Why?
|
Permeability | 1 | 2005 | 726 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 1992 | 2055 | 0.010 |
Why?
|
Life Style | 1 | 2014 | 3932 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9617 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2007 | 737 | 0.010 |
Why?
|
Rats | 3 | 2005 | 23782 | 0.010 |
Why?
|
Crotalus | 1 | 2001 | 7 | 0.010 |
Why?
|
Lung | 1 | 2001 | 10101 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1759 | 0.010 |
Why?
|
Bone Marrow | 1 | 2012 | 2935 | 0.010 |
Why?
|
Genes, BRCA2 | 1 | 2005 | 593 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 2001 | 152 | 0.010 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2003 | 254 | 0.010 |
Why?
|
Gold | 1 | 2005 | 488 | 0.010 |
Why?
|
Cell Membrane | 1 | 2011 | 3655 | 0.010 |
Why?
|
Factor IX | 1 | 2001 | 76 | 0.010 |
Why?
|
Blood Platelets | 1 | 1992 | 2479 | 0.010 |
Why?
|
Lac Operon | 1 | 2001 | 237 | 0.010 |
Why?
|
Particle Size | 1 | 2005 | 1651 | 0.010 |
Why?
|
Phrenic Nerve | 1 | 2001 | 81 | 0.010 |
Why?
|
Inhalation | 1 | 2001 | 145 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2001 | 2087 | 0.010 |
Why?
|
Saline Solution, Hypertonic | 1 | 2001 | 115 | 0.010 |
Why?
|
Health Personnel | 1 | 2014 | 3384 | 0.010 |
Why?
|
Bile Ducts | 1 | 2001 | 288 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6340 | 0.010 |
Why?
|
Child | 2 | 2020 | 80917 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 1142 | 0.010 |
Why?
|
Nanostructures | 1 | 2005 | 553 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2956 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 2001 | 172 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2001 | 575 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2012 | 26379 | 0.010 |
Why?
|
Catheterization | 1 | 2005 | 1430 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4539 | 0.010 |
Why?
|
Cell Line | 2 | 2005 | 15602 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 713 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 930 | 0.010 |
Why?
|
Portal Vein | 1 | 2001 | 435 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10099 | 0.010 |
Why?
|
Vagus Nerve | 1 | 2001 | 459 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8509 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3929 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4149 | 0.010 |
Why?
|
Canada | 1 | 2003 | 2130 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3905 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2001 | 741 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8890 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1481 | 0.010 |
Why?
|
Axilla | 1 | 1998 | 623 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2479 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 3346 | 0.010 |
Why?
|
Chronic Disease | 2 | 2001 | 9384 | 0.010 |
Why?
|
Electromyography | 1 | 2001 | 1401 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6209 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11677 | 0.010 |
Why?
|
Ligands | 1 | 2001 | 3284 | 0.010 |
Why?
|
Imipenem | 1 | 1993 | 38 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22380 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 6019 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6231 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 1993 | 198 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 13091 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2001 | 4834 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8741 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1993 | 238 | 0.010 |
Why?
|
Hirudins | 1 | 1992 | 179 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1993 | 342 | 0.010 |
Why?
|
Mice | 2 | 2012 | 82049 | 0.010 |
Why?
|
Image Enhancement | 1 | 2001 | 2880 | 0.010 |
Why?
|
Lipids | 1 | 2001 | 3345 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13422 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2001 | 2726 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17623 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1992 | 769 | 0.000 |
Why?
|
Platelet Activation | 1 | 1992 | 644 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2001 | 2334 | 0.000 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4064 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1993 | 1967 | 0.000 |
Why?
|
Models, Statistical | 1 | 2001 | 5107 | 0.000 |
Why?
|
Tissue Plasminogen Activator | 1 | 1992 | 1165 | 0.000 |
Why?
|
Heparin | 1 | 1992 | 1636 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20762 | 0.000 |
Why?
|
Schizophrenia | 1 | 2001 | 6983 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1993 | 7477 | 0.000 |
Why?
|